152 related articles for article (PubMed ID: 38085348)
1. Label-free microfluidic chip for segregation and recovery of circulating leukemia cells: clinical applications in acute myeloid leukemia.
Ouyang D; Ye N; Jiang Y; Wang Y; Hu L; Chao S; Yarmush M; Tuner M; Li Y; Tang B
Biomed Microdevices; 2023 Dec; 26(1):3. PubMed ID: 38085348
[TBL] [Abstract][Full Text] [Related]
2. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood.
Jackson JM; Taylor JB; Witek MA; Hunsucker SA; Waugh JP; Fedoriw Y; Shea TC; Soper SA; Armistead PM
Analyst; 2016 Jan; 141(2):640-51. PubMed ID: 26523411
[TBL] [Abstract][Full Text] [Related]
3. Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications.
Ouyang D; Ye N; Yang K; Wang Y; Hu L; Chao S; Toner M; Li Y
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067399
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic chip with reversible interface for noninvasive remission status monitoring and prognosis prediction of acute myeloid leukemia.
Lai Q; Song J; Zha J; Zheng H; Deng M; Liu Y; Lin W; Zhu Z; Zhang H; Xu B; Yang C
Biosens Bioelectron; 2023 Jan; 219():114803. PubMed ID: 36252315
[TBL] [Abstract][Full Text] [Related]
5. Detection of NPM1 Mutations in Acute Myeloid Leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application.
Jin Y; Xu ZJ; Yu D; Xia PH; Yao DM; Yuan Q; Li T; Xiang HL; Ma JC; Wen XM; Lin J; Qian J
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948486
[TBL] [Abstract][Full Text] [Related]
6. Isolation of acute myeloid leukemia blasts from blood using a microfluidic device.
Teixeira A; Sousa-Silva M; Chícharo A; Oliveira K; Moura A; Carneiro A; Piairo P; Águas H; Sampaio-Marques B; Castro I; Mariz J; Ludovico P; Abalde-Cela S; Diéguez L
Analyst; 2024 May; 149(10):2812-2825. PubMed ID: 38644740
[TBL] [Abstract][Full Text] [Related]
7.
Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
Turk J Haematol; 2018 Mar; 35(1):49-53. PubMed ID: 29129825
[TBL] [Abstract][Full Text] [Related]
8. Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNA.
Rausch C; Rothenberg-Thurley M; Buerger SA; Tschuri S; Dufour A; Neusser M; Schneider S; Spiekermann K; Metzeler KH; Ziemann F
J Mol Diagn; 2021 Aug; 23(8):975-985. PubMed ID: 34020042
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
10. [Detection of NPM1 Mutation in Acute Myeloid Leukemia by Droplet Digital PCR and Its Clinical Application Value].
Jin Y; Wang SS; Xia PH; Yuan Q; Xiao GF; Lin J; Leng JY; Ma YJ; Qian J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):653-658. PubMed ID: 35680787
[TBL] [Abstract][Full Text] [Related]
11. Digital PCR-based
Hua J; Chu M; Wang C; Zhang H; Luan J; Zhang Y; Li Q; Xiao T; Zhu C; Li X; Fu B
Epigenomics; 2024 Feb; 16(4):233-247. PubMed ID: 38343387
[No Abstract] [Full Text] [Related]
12. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
13. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
14. Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Bill M; Grimm J; Jentzsch M; Kloss L; Goldmann K; Schulz J; Beinicke S; Häntschel J; Cross M; Vucinic V; Pönisch W; Behre G; Franke GN; Lange T; Niederwieser D; Schwind S
Ann Hematol; 2018 Oct; 97(10):1757-1765. PubMed ID: 29785446
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells.
M Weerakoon-Ratnayake K; Vaidyanathan S; Larky N; Dathathreya K; Hu M; Jose J; Mog S; August K; K Godwin A; L Hupert M; A Witek M; A Soper S
Cells; 2020 Feb; 9(2):. PubMed ID: 32102446
[TBL] [Abstract][Full Text] [Related]
16. Minimal/Measurable Residual Disease Monitoring in
Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
[TBL] [Abstract][Full Text] [Related]
17. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of newly diagnosed acute myeloid leukemia with myelodysplasia related changes and elderly acute myeloid leukemia following decitabine therapy in combination with priming regimen.
Lai B; Mu Q; Zhang Y; Chen Y; Yan X; Ouyang G
Hematology; 2021 Dec; 26(1):751-757. PubMed ID: 34555298
[TBL] [Abstract][Full Text] [Related]
19. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
20. Droplet digital PCR for genetic mutations monitoring predicts relapse risk in pediatric acute myeloid leukemia.
Chen X; Liu L; Zhang A; Yi M; Lan Y; Zheng Z; Zhang L; Liu X; Chang L; Zou Y; Ruan M; Zhu X
Int J Hematol; 2022 Nov; 116(5):669-677. PubMed ID: 35849248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
